Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-015979
Filing Date
2013-11-01
Accepted
2013-11-01 19:50:06
Documents
1
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3977
  Complete submission text file 0001179110-13-015979.txt   5497
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address
Kumar Hari (Reporting) CIK: 0001588968 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55021 | Film No.: 131187383